1. Attenuated cytarabine, etoposide, dexamethasone plus rituximab (R‐Mini‐CYVE) regimen for patients with relapsed or refractory B‐cell non–Hodgkin's lymphoma not eligible for intensive chemotherapy. (4th February 2021) Authors: Abdayem, Pamela; Ibrahim, Nathalie; El Dakdouki, Yolla; Willekens, Christophe; Ghez, David; A. Rouche, Julia; Dartigues, Peggy; Desmaris, Romain; Danu, Alina; Rossignol, Julien; Lazarovici, Julien; Fermé, Christophe; Ribrag, Vincent; Michot, Jean M. Journal: European journal of haematology Issue: Volume 106:Number 4(2021) Page Start: 574 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Chemotherapy beyond immune checkpoint inhibitors in patients with metastatic colorectal cancer. (September 2020) Authors: Martin-Romano, Patricia; Ammari, Samy; El-Dakdoukti, Yolla; Baldini, Capucine; Varga, Andreea; Vuagnat, Perrine; Angevin, Eric; Bahleda, Rastislav; Gazzah, Anas; Champiat, Stephane; Michot, Jean M.; Postel-Vinay, Sophie; Marabelle, Aurelien; Soria, Jean C.; Boige, Valerie; Malka, David; Ducreux, ... Journal: European journal of cancer Issue: Volume 137(2020) Page Start: 117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗